‘We May Need Even More’: Biden Doubles Pfizer’s Covid Pills Ordernews2022-01-05T00:24:37+00:00January 5th, 2022|The New York Times|
F.D.A. Plans to Allow 12- to 15-Year-Olds to Receive Pfizer Boostersnews2021-12-31T02:43:34+00:00December 31st, 2021|The New York Times|
J. & J. Booster Protects Against Severe Omicron, Study Saysnews2021-12-30T10:45:18+00:00December 30th, 2021|The New York Times|
South Korea approves Pfizer’s coronavirus pill for emergency use.news2021-12-28T00:19:17+00:00December 28th, 2021|The New York Times|
Merck’s Covid Pill Is Authorized by F.D.A. for High-Risk Adultsnews2021-12-24T02:19:46+00:00December 24th, 2021|The New York Times|
Beneath a Covid Vaccine Debacle, 30 Years of Government Culpabilitynews2021-12-23T10:00:26+00:00December 23rd, 2021|The New York Times|
Walgreens and CVS Limit Purchases of At-Home Coronavirus Testsnews2021-12-23T04:03:53+00:00December 23rd, 2021|The New York Times|
Novavax’s Covid Vaccine Is Authorized in Europenews2021-12-21T04:57:33+00:00December 21st, 2021|The New York Times|
Senators Question Califf, the F.D.A. Nominee, on Opioid Crisis and Pandemic Responsenews2021-12-14T23:44:00+00:00December 14th, 2021|The New York Times|
Merck’s Covid Pill Might Pose Risks for Pregnant Womennews2021-12-13T15:27:03+00:00December 13th, 2021|The New York Times|
